Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Quince Therapeutics Inc., 3 years.
Quince Therapeutics Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Quince Therapeutics Inc. June 5, 202493.1%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 14, 2023 | Quince Therapeutics Inc. | Open-market purchase | +22,627 | $1.04 | $23,532 |
| Dec 13, 2023 | Quince Therapeutics Inc. | Open-market purchase | +22,627 | $1.00 | $22,627 |
| Dec 12, 2023 | Quince Therapeutics Inc. | Open-market purchase | +300 | $1.00 | $300 |
| Dec 12, 2023 | Quince Therapeutics Inc. | Open-market purchase | +22,327 | $1.02 | $22,774 |
| Dec 7, 2023 | Quince Therapeutics Inc. | Open-market purchase | +19,123 | $1.01 | $19,314 |
| Dec 6, 2023 | Quince Therapeutics Inc. | Open-market purchase | +19,123 | $1.02 | $19,505 |
| Dec 5, 2023 | Quince Therapeutics Inc. | Open-market purchase | +19,123 | $1.01 | $19,314 |
| Dec 1, 2023 | Quince Therapeutics Inc. | Open-market purchase | +14,378 | $0.94 | $13,515 |
| Nov 30, 2023 | Quince Therapeutics Inc. | Open-market purchase | +14,378 | $0.90 | $12,940 |
| Nov 29, 2023 | Quince Therapeutics Inc. | Open-market purchase | +14,378 | $0.98 | $14,090 |
| Aug 31, 2023 | Quince Therapeutics Inc. | Open-market purchase | +41,026 | $1.32 | $54,154 |
| Aug 30, 2023 | Quince Therapeutics Inc. | Open-market purchase | +41,026 | $1.31 | $53,744 |
| Aug 17, 2023 | Quince Therapeutics Inc. | Open-market purchase | +24,766 | $1.29 | $31,948 |
| Aug 16, 2023 | Quince Therapeutics Inc. | Open-market purchase | +117,348 | $1.29 | $151,379 |
| Aug 15, 2023 | Quince Therapeutics Inc. | Open-market purchase | +107,886 | $1.32 | $142,410 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.